Skip to main content

Nexus Pharmaceuticals Launches Fluorescein 2 mL

Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL vial alongside Fluorescein Injection, USP 10% in a 5 mL vial. Nexus is committed to enhancing the availability of Fluorescein across the optometry market.

Fluorescein 2 mL and 5 mL are available in cartons of ten. Order your supply of 2 mL Fluorescein Injection, USP 25% directly through your Wholesalers or from Customer Service at (888) 806-4606.

Unit of sale NDC: 14789-0123-05

  • Cencora – 10298239
  • Cardinal – 5977483
  • McKesson – 3020054
  • Morris & Dickson - 594374

About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they’re needed most.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.51
+11.26 (5.09%)
AAPL  260.78
+1.88 (0.73%)
AMD  236.90
+5.08 (2.19%)
BAC  52.80
+0.91 (1.76%)
GOOG  316.63
+1.89 (0.60%)
META  628.51
+16.09 (2.63%)
MSFT  373.37
-0.96 (-0.26%)
NVDA  183.93
+1.85 (1.02%)
ORCL  137.59
-5.56 (-3.89%)
TSLA  345.26
+2.01 (0.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.